A Study of Avacopan in Participants With Normal Renal Function and Participants With End-Stage Renal Disease (ESRD)

Clinical trial NCT06468826 · COMPLETED

Trial details

NCT number: NCT06468826
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

End-Stage Renal Disease (ESRD)

Start date: 2024-06-18
Primary completion: 2024-10-05
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.